The Blood-Brain Barrier Is a Living Wall

In 1885, Paul Ehrlich injected a blue dye into the bloodstream of a rabbit and dissected it. Every tissue stained blue — except the brain and spinal cord. He assumed the brain simply had no affinity for the dye. His student Edwin Goldmann reversed the experiment in 1913: blue dye injected into cerebrospinal fluid stained only the brain. Whatever was keeping the dye out was selective, and it was operating at the boundary.

That boundary is the blood-brain barrier. It is not a single membrane. It is the endothelial cells lining the capillaries of the brain, sealed to each other with unusually tight junctions and wrapped in a second layer of support cells called astrocytes. Most capillaries in the body have small gaps that let water, ions, and small molecules leak through. Brain capillaries do not.

What gets through is strictly controlled. Oxygen and carbon dioxide diffuse freely. Glucose crosses via the GLUT1 transporter. Amino acids have their own carrier. Most drugs — including most antibiotics, antidepressants, and nearly all large-molecule biologics — do not cross. That is why brain infections such as bacterial meningitis are medically dangerous in ways that other infections are not; the immune system and the pharmacy are largely on the wrong side of the wall.

A few specialized regions deliberately lack the barrier. The circumventricular organs — including the area postrema and median eminence — are permeable because they need to sample the blood's chemistry to regulate thirst, nausea, and hormone release. Those regions are where every antiemetic drug does its work.

Disrupting the barrier is a neuro-oncology frontier. Focused ultrasound with microbubbles can open the wall reversibly, letting chemotherapy reach gliomas that otherwise would not see the dose.